Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

ClinicalTrials.gov ID: NCT00483652

Public ClinicalTrials.gov record NCT00483652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis

Study identification

NCT ID
NCT00483652
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Acorda Therapeutics
Industry
Enrollment
240 participants

Conditions and interventions

Interventions

  • Fampridine-SR Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2007
Primary completion
Jan 31, 2008
Completion
Apr 30, 2008
Last update posted
Feb 3, 2016

2007 – 2008

United States locations

U.S. sites
36
U.S. states
24
U.S. cities
34
Facility City State ZIP Site status
Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix Arizona 85013
HOPE Research Institute Phoenix Arizona 85050
Neurological Associates Fayetteville Arkansas 72703
Alta Bates Summit Medical Center - Research and Education Institute Berkeley California 94705
USC, Keck School of Medicine Health Care Consultation Center Los Angeles California 90033
UC Davis Sacramento California 95817
Yale University MS Center New Haven Connecticut 06510
Shepherd Center Atlanta Georgia 30309
Consultants in Neurology, Ltd. Northbrook Illinois 60062
Indiana University MS Center Indianapolis Indiana 46202
Associates in Neurology, PSC Lexington Kentucky 40503
Maryland Center for MS Baltimore Maryland 21201
Lahey Clinic Lexington Massachusetts 02421
The Schapiro Center for MS Golden Valley Minnesota 55422
Washington University School of Medicine St Louis Missouri 63110
Advanced Neurology Specialists Great Falls Montana 59405
UMDNJ Newark New Jersey 07103
Gimbel MS Center at Holy Name Hospital Teaneck New Jersey 07666
Jacobs Neurological Institute Buffalo General Hospital Buffalo New York 14203
Corinne Goldsmith Dickinson Center for MS New York New York 10029
Columbia University Multiple Sclerosis Clinical Care Center New York New York 10032
University of Rochester Rochester New York 14642
SUNY Stony Brook Stony Brook New York 11794
CMC - Neuroscience & Spine Institute, Division of Neurology Charlotte North Carolina 28207
Raleigh Neurology Associates Raleigh North Carolina 27607
Wake Forest University, Dept of Neurology, M.S. Research Winston-Salem North Carolina 27157
The Center for Neurological Services Bismarck North Dakota 58501
Cleveland Clinic Foundation Cleveland Ohio 44195
Ohio State University MS Center Columbus Ohio 43221
Oregon Health & Science University, MS Center of Oregon, UHS-42 Portland Oregon 97239
Thomas Jefferson University Physicians Philadelphia Pennsylvania 19107
Neurological Research Center, Inc. Bennington Vermont 05201
Fletcher Allen Health Care Burlington Vermont 05401
MS Center at Evergreen Kirkland Washington 98034
CAMC Health Education & Research Institute Charleston West Virginia 25304
Center for Neurological Disorders of Aurora, St. Luke's Medical Center Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00483652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2016 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00483652 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →